Incyte today announced positive topline results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19 ...
Dualboot Partners today launched DB90, an AI ecosystem for the full SDLC, including planning, design, development, testing, and deployment that increases productivity and delivers better software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback